Greenwich LifeSciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GLSI Nasdaq 2836 greenwichlifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Greenwich LifeSciences, Inc.

Top Midday Gainers - Dec 29th, 2025 10:50 am
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 - Dec 29th, 2025 4:00 am
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy - Dec 22nd, 2025 4:00 am
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 - Dec 15th, 2025 4:00 am
Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 - Dec 8th, 2025 4:00 am
Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date - Dec 3rd, 2025 4:00 am
Several Insiders Invested In Greenwich LifeSciences Flagging Positive News - Nov 14th, 2025 3:43 am
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial - Oct 9th, 2025 4:00 am
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium - Oct 2nd, 2025 4:00 am
Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial - Sep 30th, 2025 4:00 am
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland - Sep 18th, 2025 4:00 am
Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation - Sep 10th, 2025 4:00 am
Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences - Aug 20th, 2025 7:25 am
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team - Aug 19th, 2025 4:00 am
Owning 53% in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) means that insiders are heavily invested in the company's future - Aug 16th, 2025 8:00 am
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania - Aug 13th, 2025 4:00 am
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events - Aug 11th, 2025 4:00 am
Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Jun 27th, 2025 7:00 am
Greenwich LifeSciences Provides Global Update on FLAMINGO-01 - Apr 3rd, 2025 6:00 am
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial - Apr 2nd, 2025 4:00 am